Clinical Course of Three Postoperative Symptomatic COVID-19 Cases in Patients After Lung Lobectomy

Ann Thorac Surg. 2020 Dec;110(6):e461-e463. doi: 10.1016/j.athoracsur.2020.06.001. Epub 2020 Jun 6.

Abstract

The novel coronavirus disease 2019 is a highly contagious viral infection caused by the severe acute respiratory syndrome coronavirus 2 virus. Its rapid spread and severe clinical presentation influence patient management in all specialties including thoracic surgery. We report 3 cases of coronavirus disease 2019 occurring in patients shortly after thoracotomy and thoracoscopy procedures, illustrating the imminent threat of severe acute respiratory syndrome coronavirus 2 infection for thoracic surgery patients.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / pathology
  • Adenocarcinoma / surgery
  • Aged
  • Betacoronavirus*
  • COVID-19
  • Carcinoma, Squamous Cell / pathology
  • Carcinoma, Squamous Cell / surgery
  • Coronavirus Infections / diagnosis*
  • Coronavirus Infections / etiology
  • Coronavirus Infections / therapy
  • Cross Infection / diagnosis*
  • Cross Infection / etiology
  • Cross Infection / therapy
  • Female
  • Humans
  • Lung Neoplasms / pathology
  • Lung Neoplasms / surgery*
  • Male
  • Middle Aged
  • Pandemics
  • Pneumonectomy / adverse effects*
  • Pneumonia, Viral / diagnosis*
  • Pneumonia, Viral / etiology
  • Pneumonia, Viral / therapy
  • Postoperative Complications / diagnosis*
  • Postoperative Complications / etiology
  • Postoperative Complications / therapy
  • SARS-CoV-2
  • Thoracoscopy / adverse effects
  • Thoracotomy / adverse effects